UCB reveals new Bimzelx 'complete skin clearance' data
Positive data represents a boost for patients with moderate to severe plaque psoriasis - News - PharmaTimes
Source: pharmatimes.com
Page 7 - Bruce Strober News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bruce Strober. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bruce Strober Today - Breaking & Trending Today
Tapinarof Effective for Longer-Term Treatment of Plaque Psoriasis
WEDNESDAY, July 13, 2022 (HealthDay News) -- Four in 10 plaque psoriasis patients achieve complete disease clearance with tapinarof cream, 1 percent, according to a study published online June 26 in the Journal of the American Academy of Dermatology. Bruce Strober, M.D., Ph.D., from Yale University in New Haven, Connecticut, and colleagues assessed the long-term
Source: physiciansweekly.com
New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Evelo Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
An important external recognition of the potential of SINTAX medicines. We believe this puts EDP1815 and SINTAX medicines in a strong position as we move closer to realizing our vision to improve... | March 24, 2022
Source: marketscreener.com
Durable and Deepening Clinical Responses Observed in Post-Treatment Period of Evelo Bioscience's Phase 2 Clinical Trial of Oral EDP1815 in Psoriasis
Durable and Deepening Clinical Responses Observed in Post-Treatment Period of Evelo Bioscience’s Phase 2 Clinical Trial of Oral EDP1815 in Psoriasis - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com